A correlation between NCAPG2 and the three ICI therapeutic markers mentioned above was analyzed in our study, which shows significant correlations between NCAPG2 expression in STAD, GBM, LUAD, KICH and ACC tumors, suggesting the potential for further tumor classification based on these three markers or for specific therapeutic treatment. The gene discussed is NCAPG2; the disease is glioblastoma.